| Survey About Diet in Chronic Inflammatory Rheumatic Diseases (NCT05283096) | Poitiers University Hospital | 2022-02-10 |
| A Study of CC-99677 in Participants With Active Ankylosing Spondylitis (NCT04947579) | Celgene | 2021-08-25 |
| Frequency of Pes Planus and Posterior Tibial Tendon Dysfunction in Patients With Ankylosing Spondylitis (NCT04810715) | Afyonkarahisar Health Sciences University | 2021-03-01 |
| The Relationship Between Inflammatory ARTritis and CArdiac DIseAse (NCT05647577) | University Hospital, Gentofte, Copenhagen | 2021-01-01 |
| Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response. (NCT04731831) | Aalborg University Hospital | 2020-08-01 |
| Enhanced Clinics for Patients Diagnosed With Ankylosing Spondylitis and Psoriatic Arthritis (NCT04341233) | NHS Lothian | 2020-08-01 |
| Novel Quantitative MRI for Axial Spondyloarthritis (NCT03778515) | The Cleveland Clinic | 2020-01-15 |
| Effects of Tai Chi in Patients With Ankylosing Spondylitis Receiving Anti-tumor Necrosis Factor Alpha Therapy (NCT03807180) | Pamukkale University | 2019-01-25 |
| A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis (NCT03733925) | Johnson & Johnson Private Limited | 2019-01-07 |
| One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study (NCT03662919) | Biogen | 2018-07-02 |
| Prediction of Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive SpA (NCT03561649) | University Hospital, Grenoble | 2018-06-14 |
| The Effect of Mobile Application on Subcutaneous Anti-TNF Drug Administration:Ankylosing Spondylitis Patients (NCT04301128) | Eskisehir Osmangazi University | 2017-12-27 |
| Analysis of DNA Methylation in Spondyloarthritis (NCT03092583) | Centre Hospitalier Universitaire de Besancon | 2017-02-15 |
| Prediction of the Answer to the Treatment by Biotherapies for Naive Spondyloarthritis by Combinatorial Analysis of Serum Biomarkers (NCT03033095) | University Hospital, Grenoble | 2016-07-01 |
| A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis (NCT02809781) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2016-06-01 |
| Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA (NCT02509026) | Pfizer | 2015-09-24 |
| Biopsychosocial Exploration of Pain Profiles in Inflammatory and Chronic Non-specific Axial Low Back Pain (NCT02704845) | University of Dublin, Trinity College | 2015-09-01 |
| 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis (NCT02159053) | Novartis Pharmaceuticals | 2015-05-18 |
| An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement (NCT02293681) | Janssen Research & Development, LLC | 2015-04-10 |
| Increasing Physical Activity in Ankylosing Spondylitis: a Randomised Controlled Trial (NCT02374502) | University of Dublin, Trinity College | 2015-03-01 |
| Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS) (NCT01870284) | Eli Lilly and Company | 2014-07-01 |
| Physiotherapy-led Outpatient Clinic for Patients With Spondyloarthritis (NCT02098694) | Norwegian University of Science and Technology | 2014-06-01 |
| 16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients (NCT02008916) | Novartis Pharmaceuticals | 2014-01-14 |
| Extension in AS: Sustainability of Benefits, Safety and Tolerability (NCT01863732) | Novartis Pharmaceuticals | 2013-11-06 |
| A Multicenter Registry of Adalimumab in Chinese Adult Patients With Active Ankylosing Spondylitis (NCT01901627) | Peking Union Medical College Hospital | 2013-04-01 |
| Treat-to-Target Strategy With Etanercept for Ankylosing Spondylitis (NCT03880968) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2012-03-01 |
| Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006) (NCT01453725) | Merck Sharp & Dohme LLC | 2012-02-13 |
| Natural History and Development of Spondyloarthritis (NCT01422694) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2011-08-12 |
| Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes (NCT01258738) | Pfizer | 2011-02-01 |
| A Study of Tocilizumab (RoActemra/Actemra) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous Tumor Necrosis Factor (TNF) Antagonist Therapy (NCT01209689) | Hoffmann-La Roche | 2010-10-01 |
| A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108) (NCT01208207) | Organon and Co | 2010-09-27 |
| A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs (NCT01209702) | Hoffmann-La Roche | 2010-09-01 |
| Ultrasound of Enthesis in Patients With Ankylosing Spondylitis: a Comparative Study With Health Subjects (NCT01567878) | University of Sao Paulo | 2009-05-01 |
| An Efficacy and Safety Study of Tramadol/Acetaminophen Versus Diclofenac in the Treatment of Pain in Participants With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs) (NCT00766402) | Johnson & Johnson Taiwan Ltd | 2008-09-01 |
| A Study Investigating an Exercise and Education Programme for Individuals With Ankylosing Spondylitis (NCT00764686) | University College Dublin | 2008-06-01 |
| Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis (NCT01188655) | Pfizer | 2008-05-01 |
| Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440) (NCT00686894) | Merck Sharp & Dohme LLC | 2008-01-01 |
| Relapse of Ankylosing Spondylitis Patients Withdrawal Etanercept After Clinical Remission: a Following-up Study (NCT02915354) | Sun Yat-sen University | 2007-07-01 |
| An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants (NCT00760669) | Janssen Korea, Ltd., Korea | 2007-05-01 |
| C.O.R.P.U.S.: Observational Cohort of Adult and Child Inflammatory Arthritis in France (NCT02886689) | Central Hospital, Nancy, France | 2007-01-01 |
| Assessment of SpondyloArthritis Society (ASAS) Classification and Diagnostic Criteria for Early Axial Spondyloarthritis (SpA) (NCT00328068) | Charite University, Berlin, Germany | 2006-07-01 |
| Methotrexate in the Treatment of Axial Spondyloarthritis (NCT00298012) | Rheumatism Foundation Hospital | 2006-03-01 |
| Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis (NCT00273858) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-03-01 |
| Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) (NCT00727298) | Merck Sharp & Dohme LLC | 2006-02-01 |
| A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis (NCT00265083) | Centocor, Inc. | 2005-12-01 |
| Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment (Study P04465)(COMPLETED) (NCT00778869) | Merck Sharp & Dohme LLC | 2005-08-01 |
| Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (Study P04352) (NCT00202865) | Merck Sharp & Dohme LLC | 2005-05-01 |
| A Study of the Efficacy and Tolerance of Remicade in the Treatment of Active Ankylosing Spondylitis (Study P04042)(COMPLETED) (NCT00779012) | Merck Sharp & Dohme LLC | 2004-10-01 |
| Growth Factor Concentration to Predict an Ankylosing Spondylitis Patient's Response to Infliximab (Study P04041)(COMPLETED) (NCT00779935) | Merck Sharp & Dohme LLC | 2004-10-01 |
| Investigation of 9 Consecutive Remicade Infusions in Ankylosing Spondylitis in Austria (Study P04044)(COMPLETED) (NCT00725543) | Merck Sharp & Dohme LLC | 2004-06-01 |
| Remicade Safety Line (Ankylosing Spondylitis)(Study P03275)(COMPLETED) (NCT00818168) | Merck Sharp & Dohme LLC | 2003-07-01 |
| Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis (NCT02183168) | Boehringer Ingelheim | 2001-07-01 |
| Blocking Tumor Necrosis Factor in Ankylosing Spondylitis (NCT00000433) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1999-10-01 |